1. What is the Chemxpert database?

Chemxpert database is a techno-commercial information platform developed and operated by Lifescience Intellipedia Pvt. Ltd. Our data provides valuable insights regarding sourcing, marketing, development, and regulatory functions for the entire Lifescience industry. The different industries covered by our data encompass APIs, FDFs, pharma intermediates, paints, dyes, polymers, biotechnology, biochemical, food additives, nutraceuticals, etc.

2. How can I subscribe to the Chemxpert database?

You can gain access to the Chemxpert database after subscribing to it by visiting this link: - https://chemxpert.com/pricing

3. How many countries' data is available on your portal?

The Chemxpert database covers more than 200 countries. We are working in the direction of expanding our data coverage in more countries.

4. What are the different sources you use for obtaining information?

The different sources we use for data collection are as follows: - • Primary researc • DMF, ANDA, & CEP list • Conferences, Exhibitions, & Tradeshow • Company annual reports • DMF, ANDA, & CEP list • Subject matter experts & KOL survey. Apart from these, our other valuable sources include application-wise manufacturers list, subscribed and non-subscribed databases, corporate partners, US FDA Orange book, publicly available sources, industry associates, national statistics, regulatory websites, etc. You can gain access to the Chemxpert database after subscribing to it by visiting this link: -https://chemxpert.com/sources

5. What is the expected time for account activation?

Your Chemxpert account will be activated instantly if the payment is made through our website. If you choose to use RTGS, NEFT, or IMPS systems for payment, your account will be activated within 24 hours.

24 Feb 2024
Admin
News Article

Orchid Pharma’s Enmetazobactam Receives US FDA Approval

Chennai-based Orchid Pharma has received approval from the United States Food and Drug Administration (FDA) for its novel invention, ‘Enmetazobactam’. This development comes in close succession to the recent recommendation for approval by the European Medicines Agency (EMA). Enmetazobactam is the first completely invented-in-India beta lactamase inhibitor.

This US FDA approval paves the way for the introduction of enmetazobactam in the United States, the largest pharmaceutical market in the world. The product is expected to be launched within the next couple of quarters in the US market.

New Use of Exblifep

This New Drug Approval (NDA) allows the use of Exblifep (cefepime and enmetazobactam) as an injection for the treatment of patients 18 years and older with complicated urinary tract infections (cUTI) including pyelonephritis caused by the following susceptible microorganisms: Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Proteus mirabilis, and Enterobacter cloacae complex.

Being First in India

Orchid is the first company from India, ever to have invented a product which has received a New Drug Approval (NDA) from US FDA. It is a significant development in addressing the global need for affordable and efficacious drugs to combat anti-microbial resistance (AMR).

Words from Orchid Pharma

On this occasion, Manish Dhanuka, managing director - Orchid Pharma, said, “While EMA recommendation for grant of marketing authorization last month was a big achievement, the US FDA approval reinforces Orchid’s position on the safety of the drug and its innate need in the times of increasing antimicrobial resistance.
First discovered in 2008, it has taken 16 years of pain staking work to get the product to market. During this time countless tests were done to establish its safety and efficacy and generate data for submission to regulatory authorities worldwide,” he added.

About Enmetazobactam

Enmetazobactam was invented in India by Orchid and then out licensed to Allecra Therapeutics for further development.
With the potential to save thousands of lives globally, this approval by US FDA is a testament to Indian ingenuity.
It is also a matter of great pride that as the pharmacy of the world, India has finally developed a new drug for the first time.

About Orchid

Established in 1992 as an export-oriented unit (EOU), Orchid Pharma Ltd. (Orchid) is a vertically integrated company spanning the entire pharmaceutical value chain with established credentials in research, manufacturing, and marketing.

Let’s apply Data-Driven Pricing to Your APIs

Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.

Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.

Start using market intelligence today and allow yourself to be in control in the API market.

Check it out today and make more informed sourcing decisions! Learn More!